SCHEMBL31411422

SCHEMBL31411422

COc1ccc(F)c2[nH]nc(CCN3CCC3)c12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR1A P08908 2/20 0.45
▸ HRH3 Q9Y5N1 2/20 0.40
▸ SIGMAR1 Q99720 5/20 0.39
▸ KCNH2 Q12809 2/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ GFER P55789 1/20 0.38
▸ HTR2A P28223 2/20 0.36
▸ DRD2 P14416 1/20 0.36
▸ DRD1 P21728 1/20 0.36
▸ HTR2C P28335 1/20 0.36
▸ ABCC1 P33527 2/20 0.36
▸ ADRA1D P25100 1/20 0.36
▸ ADRA1A P35348 1/20 0.36
▸ ADRA1B P35368 1/20 0.36
▸ CYP3A4 P08684 1/20 0.35
▸ EBP Q15125 2/20 0.34
▸ POLB P06746 2/20 0.34
▸ TMEM97 Q5BJF2 1/20 0.34
▸ MEN1 O00255 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31411358 0.98 HTR1A (0.47) HTR1AHRH3SIGMAR1KCNH2KDM4E
Fumaric Acid SCHEMBL31411390 0.91 ACHE (0.39) HTR1ASIGMAR1KDM4EMAPK1GFER
SCHEMBL31411362 0.79 HTR1A (0.36) HTR1AHRH3DRD2
SCHEMBL31411305 0.77 HTR1A (0.43) HTR1AKDM4EHTR2AHTR2C
SCHEMBL31411489 0.76 HTR1A (0.42) HTR1AHRH3SIGMAR1KCNH2KDM4E
SCHEMBL31411332 0.74 ALDH1A1 (0.36) HTR1AKDM4EHTR2ADRD2HTR2C
SCHEMBL31411361 0.74 HTR1A (0.39) HTR1AHRH3HTR2ACYP3A4
SCHEMBL31411340 0.73 HTR1A (0.33) HTR1AKDM4EHTR2A
SCHEMBL31411448 0.73 HTR1A (0.40) HTR1AHRH3SIGMAR1KCNH2KDM4E
SCHEMBL31411365 0.71 HTR1A (0.41) HTR1AHRH3SIGMAR1HTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4735425-A1 COMPOUNDS Psylo Pty Ltd (AU) 2026-05-06 — — EP disclosed
US-20250353818-A1 Compounds Psylo Pty Ltd (AU) 2025-11-20 — — US disclosed
US-12428380-B2 Compounds Psylo Pty Ltd (AU) 2025-09-30 — — US disclosed
US-20250214943-A1 Compounds Psylo Pty Ltd (AU) 2025-07-03 — — US disclosed
WO-2025000053-A1 COMPOUNDS Psylo Pty Ltd (AU) 2025-01-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250214943-A1 Compounds NLN, SLC18A2, PYGB HTR1A 185/4885HRH3 2746/4885SIGMAR1 497/4885
US-12428380-B2 Compounds NLN, SLC18A2, PYGB HTR1A 185/4885HRH3 2746/4885SIGMAR1 497/4885
US-20250353818-A1 Compounds NLN, SLC18A2, PYGB HTR1A 185/4885HRH3 2746/4885SIGMAR1 497/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback